Boyar Asset Management Inc. Viatris Inc Transaction History

Boyar Asset Management Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$8.48 - $11.13 $424 - $556	50 Added 0.44%	11,391 $97,000
Q2 2022 Aug 08, 2022	SELL	$9.95 - $12.27 $2,726 - $3,361	-274 Reduced 2.36%	11,341 $119,000
Q1 2022 Apr 27, 2022	SELL	$9.81 - $15.4 $5,189 - $8,146	-529 Reduced 4.36%	11,615 $126,000
Q4 2021 Feb 10, 2022	SELL	$12.09 - $14.68 $1,910 - $2,319	-158 Reduced 1.28%	12,144 $164,000
Q3 2021 Oct 18, 2021	SELL	$13.25 - $15.13 $1,987 - $2,269	-150 Reduced 1.2%	12,302 $167,000
Q1 2021 May 04, 2021	SELL	$13.59 - $18.54 $2,853 - $3,893	-210 Reduced 1.66%	12,452 $174,000
Q4 2020 Feb 10, 2021	BUY	$14.3 - $18.74 $181,066 - $237,285	12,662 New	12,662 $237,000

1,097

964M

2.69M

2.34M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $13.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Boyar Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Boyar Asset Management Inc. with notifications on news.